4113.TWO We&Win Diversification Co Ltd

Industrials Construction & Engineering Taiwan OTC Exchange
12.95 TWD
Close of Nov 5, 2026
11.80 26.25
Market cap
TWD 2.99B
P/E
-
P/B
0.72x
ROE
-5.1%
Dividend yield
6.56%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 4113.TWO undervalued?

Graham number

The Graham number of We&Win Diversification Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

We&Win Diversification Co Ltd fundamental analysis

No fundamental analysis for We&Win Diversification Co Ltd yet.

We&Win Diversification Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About We&Win Diversification Co Ltd

We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public facilities construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohs…

Full company profile